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Abstract To date, seven different human histone deacetylases
(HDACs) have been identified, which fall into two distinct
classes. We have isolated and characterized a cDNA encoding a
novel human HDAC, which we name HDAC8. HDAC8 shows a
high degree of sequence similarity to HDAC1 and HDAC2 and
thus belongs to the class I of HDACs. HDAC8 is expressed in a
variety of tissues. Human cells overexpressing HDAC8 localize
the protein in sub-nuclear compartments whereas HDAC1 shows
an even nuclear distribution. In addition, the HDAC8 gene is
localized on the X chromosome at position q13, which is close to
the XIST gene and chromosomal breakpoints associated with
preleukemia. ß 2000 Federation of European Biochemical So-
cieties. Published by Elsevier Science B.V. All rights reserved.
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1. Introduction
Reversible acetylation of the N-terminal histone tails is a
key determinant of gene expression. The level of histone ace-
tylation is determined by the opposing activities of histone
acetyltransferases (HATs) and histone deacetylases (HDACs).
Generally, hyperacetylation of histones results in transcrip-
tional activation whereas deacetylation correlates with tran-
scriptional silencing [1]. Interestingly, transcriptional activa-
tors are often associated with HAT activity (reviewed in
[2,3]), whereas HDACs appear to form complexes with tran-
scriptional repressors [4^7]. The HDAC core complex consists
of HDAC1 and HDAC2 proteins associated with the
RbAp46/48 proteins [6]. This core complex can further asso-
ciate with proteins such as Sin3, MeCP2, SAP30 and SAP18
to form the Sin3^HDAC complex [6^8]. A second complex,
the Mi-2/NuRD^HDAC complex, consists of the HDAC core
complex plus MBD3, p66 and MTA-2 [6,7,9]. These HDAC
complexes are recruited to the chromatin by corepressor pro-
teins such as NcoR or SMRT and thus can speci¢cally repress
transcriptional activity [10,11].
Seven human HDACs have been described so far, falling
into two classes: I (HDAC1^3) and II (HDAC4^7). The ¢rst
HDAC, HDAC1, was identi¢ed by a⁄nity puri¢cation using
the inhibitor trapoxin [12]. Subsequently, several other
HDACs have been identi¢ed mainly based on the sequence
similarity to the prototype HDAC1. HDAC2 was identi¢ed in
a yeast two-hybrid screen using transcription factor YY1 as a
bait [13]. HDAC3 [14^16] appears to associate with other
proteins to form a complex which is distinct from the
HDAC1/2 complexes [17]. Recently, a second class of human
HDACs has been identi¢ed whose C-terminal part shows sig-
ni¢cant sequence similarity to the Saccharomyces cerevisiae
HDA1 HDAC [18^20]. HDAC4 and 5 have been shown to
interact with nuclear corepressors independent of Sin3, where-
as HDAC7 might act via multiple repression complexes
[10,20]. HDACs are involved in cell-cycle progression and
cellular di¡erentiation, and their deregulation is associated
with several cancers (reviewed in [21,22]).
Here we describe the cloning and characterization of human
HDAC8, a novel class I HDAC. Using database searches,
several overlapping expressed sequence tags (ESTs) were iden-
ti¢ed which show high similarity to class I HDACs. Tissue-
speci¢c transcription of the HDAC8 gene is di¡erent from the
other class I HDACs. The HDAC8 gene is localized on the X
chromosome at position q13, close to the X inactivation cen-
ter and close to chromosomal breakage points associated with
preleukemia.
2. Materials and methods
2.1. Bioinformatics strategy for the identi¢cation of HDAC ESTs from
databases
A multiple sequence alignment was generated using the protein
sequences of human HDAC1 (SwissProt Q13547), HDAC2 (SwissProt
Q92769) and HDAC3 (SwissProt O15379). Based on the multiple se-
quence alignment, a similarity pro¢le was calculated and applied to
subsequent pro¢le searches [23] in the SwissProt database [24]. Pos-
itive hits were used to optimize and re¢ne the multiple alignment
before searching in DNA databases. The EMBL DNA database
and Incyte EST database were probed with the proframe search pro-
gram. Searches were performed on a dedicated hardware accelerator
(Bioccelerator, Compugen, Israel).
2.2. Cloning of HDAC8 and generating recombinant cell lines
Clones containing ESTs encoding the human HDAC cDNA were
obtained from the American Type Culture Collection (clones EST
182295 and EST 87343) and from Incyte Pharmaceuticals Inc. (clone
4284291). Two primers (forward: 5P-GGC TGC GGA ACG GTT
TTA AGC-3P based on EST 182295 sequence; reverse: 5P-GAA
GCC AGC TGC CAC TTG ATG C-3P based on Incyte clone
4284291 sequence) were designed. PCR reactions were performed on
Quick-screen heart cDNA (Clontech) and the resulting 1320 bp frag-
ment was cloned into the pCR2.1topo vector (Invitrogen) and se-
quenced. DNA sequencing was carried out on double-stranded plas-
mid DNA with dye-terminator chemistry as described by the
manufacturer (Perkin Elmer/Applied Biosystems), and the products
were resolved on an ABI Prism1 377 Automated Sequencer. To ob-
tain a full-length HDAC cDNA sequence, rapid ampli¢cation of
cDNA ends (RACE) reactions were set up using Marathon-Ready
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cDNA from brain, kidney, prostate and ovary (Clontech) using the
Adaptor Primer AP1 obtained from Clontech (5P-CCA TCC TAA
TAC GAC TCA CTA TAG GGC-3P) and two nested RACE primers
(5P RACE primer: 5P-CTG ACC TTC TGG AGA TGC TGC AGA
TAA GC-3P and 3P RACE primer: 5P-GCT GGG AGC TGA CAC
AAT AGC TGG G-3P).
HDAC8/pcDNA6HisV5 was constructed by cloning the HDAC8
coding sequence upstream of and in-frame with the carboxyl-terminal
V5 epitope and His sequence into pcDNA6HisV5 (Invitrogen). Using
the same strategy, human HDAC1 (a kind gift of Dr. Yoichi Furu-
kawa) was cloned into the same vector to yield plasmid HDAC1/
pcDNA6HisV5. The constructs were veri¢ed by DNA sequencing of
the insert and multiple cloning sites.
HEK293 cells were seeded in 150 mm dishes at a density of 6U104
cells/cm2 in Dulbecco’s modi¢ed Eagle’s medium (Life Technologies)
supplemented with 10% fetal calf serum, (heat-inactivated, Biowhit-
taker), 50 U/ml penicillin/50 Wg/ml streptomycin, 1 mM L-glutamine
(Life Technologies). Plasmid DNA (HDAC1/pcDNA6HisV5;
HDAC8/pcDNA6HisV5 and pcDNA6HisV5) was transfected using
Superfect transfection reagent according to the manufacturer’s in-
structions (Qiagen). Thirty-six hours after transfection, selective me-
dium was added containing 0.5 Wg/ml blasticidin S HCl (Invitrogen).
The medium was changed every 3^4 days until foci were detected. Cell
foci were isolated and expanded. Overexpression of HDACs was veri-
¢ed by Western blot analysis using a V5 antibody. Two cell clones
each for HDAC1 and HDAC8 and one clone for pcDNA6 (insert-less
vector) were maintained.
2.3. Histone deacetylation assay
The activity of the overexpressed HDAC8 protein was measured by
incubating a [3H]acetyl-labelled fragment (amino acids 14^21) of his-
tone H4 peptide (biotin-(6-aminohexanoic)Gly-Ala-[acetyl-3H]Lys-
Arg-His-Arg-Lys-Val-NH2, 30 Ci/mmol, Amersham) and 1UHDAC
bu¡er (25 mM Tris^HCl, pH 8.0, 10% glycerol, 50 mM NaCl) with
25 Wl prepared extracts of each transfection for 60 min at 37‡C in a
total volume of 50 Wl. Assays were performed in duplicate; 50 000 cpm
of peptide was used per reaction. After incubation, the reaction was
quenched with 1 M HCl and 0.16 M acetic acid. Released [3H]acetic
acid was extracted with 120 Wl acetyl acetate and quanti¢ed by scin-
tillation counting.
Fig. 1. A: Alignment of the amino acid sequence of human class I HDACs HDAC1 (SwissProt Q13457), HDAC2 (SwissProt Q92769),
HDAC3 (SwissProt O15379) and HDAC8 (GenBank accession number AJ277724). Sequences were aligned using the ClustalW multiple se-
quence algorithm and conserved amino acid residues were annotated using the GeneDoc program. B: Phylogenetic tree of HDAC1 through
HDAC8. Sequence alignment of HDAC1 through 8 alignment was imported into TREECON (version 1.3b) using the Phylip Input File format.
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2.4. Western blot analysis
Standard protocols were followed. Lysed cell extracts or histone
preparations were heat-denatured for 5 min in Laemmli sample bu¡er.
Proteins were separated on a 12% sodium dodecyl sulphate^polyac-
rylamide gel and transferred onto polyvinylidene di£uoride membrane
(Millipore). After blocking with non-fat dried milk, the membrane
was incubated in 1:5000 diluted anti-V5 mouse monoclonal IgG2a
antibody (1.1 mg/ml, Invitrogen) followed by incubation with
1:1000 diluted anti-mouse horseradish peroxidase-conjugated IgG
from sheep (Amersham). For histone Western blots, 0.75 Wg/ml
anti-acetylated histone H4 antibody or 250 ng/ml anti-acetylated his-
tone H3 antibody (Upstate Biotechnology) were used as primary anti-
bodies. Signals were detected using the ECL+Plus Western blotting
detection system (Amersham).
2.5. Isolation of histones
Cells were grown to 70^80% con£uence and treated for 4 h with 0.5
mM trichostatin A. After treatment, cells were washed and lysed in 40
ml NIB bu¡er (1% Nonidet P-40 in IB bu¡er (10 mM Tris^HCl, pH
7.4, 2 mM MgCl2, 3 mM CaCl2 and 1 mM PMSF). Nuclei were
collected (500Ug, 5 min) and washed twice in 40 ml NIB bu¡er
followed by one wash with NIB bu¡er supplemented with 100 mM
NaCl. Nuclei were high salt-extracted in 40 ml of 400 mM NaCl and
IB bu¡er. The nuclear pellet was extracted twice in 10 volumes of
0.2 M H2SO4 for 90 min on ice and centrifuged (3500 rpm, 20 min).
Supernatants were pooled and dialyzed at 4‡C against 100 mM acetic
acid.
2.6. Immunocytochemistry
HEK293 cells were seeded at a density of 0.5U106 cells/well in
6-well plates on cover glass slips coated with poly-L-Lysine and grown
to 70^80% con£uence. As indicated, cells were treated with 40 nM
TSA. Cells were ¢xed with 2% paraformaldehyde for 30 min and
washed for 5 min in phosphate-bu¡ered saline (PBS) followed by
2 min treatment with 0.5% Triton X-100. Cells were washed for
5 min with 0.2% bovine serum albumin (BSA)/PBS and incubated
for 120 min at 37‡C in the presence of primary antibody (anti-V5
antibody (Invitrogen) diluted 1/200 in 0.2% BSA/PBS). After washing
three times for 10 min with PBS, the secondary antibody was added
(Fluorolink Cy3-labelled goat anti-mouse IgG(H+L), APBiotech) and
proceeded according to the manufacturer’s instructions. DAPI (4P,6P-
diamidino-2P-phenylindole dichloride, Roche Diagnostics) staining of
cells was carried out according to the manufacturer’s instructions.
Fluorescence signals were visualized using a £uorescence microscope
Fig. 2. Chromosomal localization of the HDAC8 gene. A: Metaphase chromosome spread labelled with £uorescent HDAC8 probe. B: The
same mitotic ¢gure stained with DAPI. C: Ideogram of the X chromosome. Cells were prepared from a female.
Fig. 3. Structure of the HDAC8 gene. Genomic sequences AL133500 and AJ239320 are indicated, sizes of introns are in kb, exon sizes are in
bp.
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(Axiovert 135, Zeiss). Cy3 £uorescence was visualized at 520 nm for
10 s, DAPI staining at 376 nm for 10 s. Images were recorded and
analyzed using MERLIN software (Life Science Resources).
2.7. Immunoprecipitation of HDACs
Cells were lysed in IPH bu¡er (50 mM Tris^HCl, pH 7.5, 150 mM
NaCl, 0.5% Nonidet P-40, 0.2 mM PMSF) and left on ice for 20 min
followed by centrifugation for 20 min at 10 000Ug at 4‡C. 5 Wg anti-
V5 antibody (Invitrogen) was added to the supernatant and rotated
for 3 h at 4‡C. 50% protein A/G Sepharose beads (Sigma) was added
and incubated at 4‡C for 1 h. Beads were washed and resuspended in
three volumes of IPH bu¡er. Deacetylation assays were performed as
above.
2.8. Northern blotting
Two human multiple tissue Northern blots and a cancer cell line
blot (all from Clontech and containing 2 Wg poly(A) RNA per lane)
were probed with a 948 bp fragment corresponding to the HDAC8
open reading frame, labelled with [32P]dCTP by random priming us-
ing the rediprime II DNA labelling system (Amersham).
2.9. Fluorescence in situ hybridization studies (FISH)
Determination of the chromosomal localization of the HDAC8
gene was carried out by SeeDNA Inc. (Ont., Canada). Lymphocytes
isolated from human blood were cultured in K-minimal essential me-
dium (K-MEM) supplemented with 10% fetal calf serum and phyto-
hemagglutinin at 37‡C for 68^72 h. The lymphocyte cultures were
treated with bromodeoxyuridine (0.18 mg/ml) to synchronize the cell
population. The synchronized cells were washed three times with se-
rum-free medium to release the bromodeoxyuridine block and recul-
tured at 37‡C for 6 h in K-MEM with thymidine (2.5 mg/ml). Cells
were harvested and slides were prepared by using standard procedures
including hypotonic treatment, ¢xation and air-drying.
A HDAC8 cDNA fragment was gel-puri¢ed and biotinylated with
dATP using the BRL BioNick labelling kit (15‡C, 1 h) [25]. The
procedure for FISH detection was performed as previously described
[25,26]. Brie£y, slides were baked at 55‡C for 1 h. After RNase treat-
ment, the slides were denatured in 70% formamide in 2USSC for
2 min at 70‡C followed by dehydration with ethanol. Probes were
denatured at 75‡C for 5 min in a hybridization mix consisting of
50% formamide and 10% dextran sulphate. Probes were loaded on
the denatured chromosomal slides. After overnight hybridization,
slides were washed and the signal detected. FISH signals and the
DAPI banding pattern were recorded separately by taking photo-
graphs, and the assignment of the FISH mapping data to chromoso-
mal bands was achieved by superimposing FISH signals with DAPI-
banded chromosomes [27].
3. Results and discussion
3.1. Cloning and sequence analysis of HDAC8
Based on the sequences of identi¢ed EST sequences, PCR
primers were designed to amplify the full-length HDAC8
cDNA. Several 5P and 3P RACE reactions were performed
in order to verify start and stop codon of the predicted
open reading frame for the HDAC cDNA (Fig. 1A). The
proposed open reading frame of HDAC8 contains 377 amino
acids with a predicted molecular mass of 42 kDa. Alignment
of the amino acid sequence of HDAC8 to HDAC1, HDAC2
and HDAC3 reveals high sequence similarity to the class I
HDACs (54% to HDAC1 and HDAC2; 39% to HDAC3;
Fig. 1A). Similarity to class II HDACs is lower, but phyloge-
netic tree analysis places HDAC8 at the boundary with class
II HDACs (Fig. 1B). The ¢rst 34 N-terminal amino acids of
HDAC8 are considerably di¡erent from those of HDAC1^3,
as are the 30 C-terminal amino acids (Fig. 1A), possibly in-
dicating a special role for both N-terminus and C-terminus in
the speci¢c function of HDAC8. A distinct stretch of mainly
acidic amino acids (HDAC8 position 83^95) is not present in
HDAC1^3, which could be an important motif for protein/
protein interactions. The central part of the protein is highly
conserved between the four class I HDACs, displaying all
seven homology regions previously identi¢ed [18]. Histidine
and aspartic acid residues shown to be important for catalytic
activity and proper folding of HDAC1 are conserved in all
human class I HDACs, including HDAC8 [17]. We conclude
that HDAC8 represents a novel human class I HDAC.
3.2. Chromosomal localization and structure of the HDAC8
gene
The chromosomal position of the HDAC8 gene was deter-
mined using FISH. Under the conditions used, the FISH de-
tection e⁄ciency was approximately 64% for the HDAC8
probe (among 100 checked mitotic ¢gures, 64 showed signals
on one pair of chromosomes) (Fig. 2A). The DAPI banding
pattern was used to establish that the HDAC8 gene localizes
to the long arm of the X chromosome (Fig. 2B). The detailed
position was further determined based upon the analysis of 10
photographs leading to the conclusion that the HDAC8 gene
is located on human chromosome X, region q13 (Fig. 2C).
Fig. 4. Northern blot analysis of HDAC8. RNA source is indicated above the lanes, 2 Wg poly(A) RNA is loaded in each lane.
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Furthermore, using the Blast program, two genomic DNA
sequences were identi¢ed (GenBank accession numbers
AJ239320 and AL133500) which contain fragments of the
HDAC8 cDNA sequence (Fig. 3). 5P exons of HDAC8 are
located on sequence AJ239320, 3P exons on the sequence
AL133500. Both sequences have an identical overlap of
8442 bp and thus can be assembled into one contig, which
contains the full-length HDAC8 gene (Fig. 3). From start to
stop codon, 11 sequences are identical to consecutive segments
of the HDAC8 cDNA sequence. Their boundaries comply
with standard exon^intron splice site rules, and their added
length equals the length of the coding sequence inferred from
our cDNA. Thus the HDAC8 gene is organized into 11 exons
over a total length of 242.7 kb (Fig. 3). The predicted open
reading frame of the HDAC8 cDNA extends on the genomic
DNA sequence for another 38 amino acids upstream to a
second potential start codon which is followed by a stop co-
don 2 amino acids further. Extensive 5P RACE reactions were
performed on cDNA from a variety of tissues but the result-
ing sequences did not extend up to this new potential start
codon. In addition, no EST sequences were found which ex-
tend into the further upstream start codon, but several cover
Fig. 5. A: Western blot analysis of HDAC overexpression in HEK293 cells. Total cell extracts from HEK293 cell clones constitutively overex-
pressing HDAC1 (clone HDAC1/15.3 and clone HDAC1/20.1) and HDAC8 (clone HDAC8/20.4 and clone HDAC8/20.5) were subjected to
Western blot analysis using an anti-V5 antibody (Invitrogen). HEK293 clone pcDNA6 is transformed with the insert-less vector and serves as a
control. B: Localization of recombinant HDACs in HEK293 cells. V5 C-terminal tagged HDAC1 (cell clone 15.3) and HDAC8 (cell clone
20.5) were detected using an anti-V5 antibody (left panels); nuclear staining using DAPI (right panels).
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the predicted start codon. The additional 38 amino acids show
no signi¢cant similarity to any other HDACs or any other
known proteins. We conclude that HDAC8 has two potential
start codons with the further 3P start codon most probably
utilized over the more 5P start codon.
Interestingly, the phosphorylase kinase K1 gene is located
only 7889 bp further downstream from exon 1 of HDAC8
(Fig. 3). This allows to map the HDAC8 gene to position
Xq13.1. This region has previously been characterized
[28,29] and comprises a highly complex DNA sequence. It
contains the brain-speci¢c NAP1L2 gene, two MAGE-like
pseudo gene clusters and several other unidenti¢ed ESTs
[29]. In addition, this region has an unusual high number of
L1 repeat sequences. Approximately 350 kb telomeric of the
HDAC8 gene lies a 100 kb region which contains isodicentric
Xq13 breakpoints which are associated with a subset of acute
myeloid leukemias (AML) and preleukemias in elderly females
[30,31]. Although the HDAC8 coding sequence lies outside of
the mapped breakpoint region, it might be possible that the
transcriptional regulation of the gene is modulated by the
mutation and thus may be potentially implicated in the gen-
eration of AML and hereditary sideroblastic anemia [30^32].
Furthermore, the isodicentric Xq13 breakpoints were mapped
450 kb centromeric to the XIST gene. The untranslated XIST
RNA is involved in initiation of X chromosome inactivation,
which correlates with histone deacetylation and DNA hyper-
methylation of the inactive X chromosome [33]. It is intrigu-
ing to ¢nd a gene for a HDAC in the chromosomal region
involved in X chromosome inactivation and future e¡orts will
focus on elucidating any involvement of HDAC8 in this pro-
cess.
3.3. Expression analysis of HDAC8
In order to establish the gene expression pro¢le of HDAC8,
a series of Northern blot hybridizations was carried out. A
major RNA species of approximately 2 kb was identi¢ed with
a second RNA band of approximately 2.2 kb in some tissues
like prostate, ovary and testis as well as in most cancer cell
lines (Fig. 4A,B). The two di¡erent RNA species detected by
Northern blot analysis might represent tissue-speci¢c splice
variants of HDAC8. Expression levels for HDAC8 were high-
est in brain, kidney and prostate which is in contrast to
HDAC1, 2 and 3, which are not expressed in brain but are
highly expressed in heart and placenta [14]. Interestingly, ex-
pression levels of HDAC8 are elevated approximately 10-fold
compared to normal tissue in seven out of eight cancer cell
lines (Fig. 4C). This was also observed for HDAC2, but not
for HDAC1 and HDAC3 [14], which is consistent with the
proposed role for histone deacetylation in some types of can-
cer [21,22]. We conclude that the expression pro¢le of
HDAC8 is distinctly di¡erent from other class I HDACs
which might imply a di¡erent biological function for HDAC8.
3.4. Overexpression of HDAC8 in mammalian cells
Cell lines were created which constitutively overexpress
HDAC8 and HDAC1 approximately 5^6-fold above untrans-
fected cells (Fig. 5A), as established using an antibody speci¢c
for HDAC1 (data not shown). Using immunocyto£uores-
cence, recombinant HDAC1 protein was detected and appears
evenly distributed in the nucleus of HEK293 cells (Fig. 5B). In
contrast, HDAC8 was primarily localized in the nucleus, but
appeared to be concentrated to sub-nuclear regions rather
than distributed evenly throughout the nucleus (Fig. 5B).
This di¡erential nuclear distribution was observed for two
di¡erent HDAC1- and HDAC8-overexpressing cell clones
and was una¡ected by the presence or absence of the
Fig. 6. A: Histone deacetylation assay using total cell extracts of
HEK293 cell lines overexpressing HDAC1 (clone 15.3 and clone
20.1), HDAC8 (clones 20.4 and 20.5) and control cell line
(pcDNA6). The average of duplicate assays is shown. B: Histone
deacetylation assay using immunoprecipitated fractions from
HDAC-overexpressing cell lines (see above). An anti-V5 antibody
was used for immunoprecipitation of V5-tagged HDAC1 and
HDAC8. C: Western blot analysis of histones isolated from
HDAC-overexpressing cells (see above). Top panel: Coomassie-
stained histones; middle panel: anti-acetyl histone H3; bottom pan-
el : anti-acetyl histone H4.
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HDAC inhibitor trichostatin A (data not shown). The signi¢-
cance of this di¡erence in distribution is not clear but one
might speculate about the targeting of HDAC8 to particular
sites in the nucleus.
Cell extracts from these recombinant cell lines were used to
assay for HDAC activity utilizing as a substrate a histone H4
peptide acetylated at lysine residue 16 (see Section 2). In a
time course experiments, total cell extracts showed increased
deacetylation activity for both HDAC1- and HDAC8-over-
expressing cell lines, as compared to the control cell line
(pcDNA6) which expresses only endogenous HDACs (Fig.
6A). HDAC1-overexpressing cell lines showed consistently
higher activities (Fig. 6A). When overexpressed HDACs
were immunoprecipitated using an antibody speci¢c for the
C-terminal V5-tag, only HDAC1-overexpressing cells showed
signi¢cant HDAC activity as compared to cells transfected
with an empty vector (Fig. 6B). Furthermore, histones were
isolated from the cell lines and the acetylation status was
assessed using antibodies speci¢c for acetylated histone H3
and H4. No signi¢cant changes in the level of histone acety-
lation were observed in the cell lines overexpressing HDAC1
and HDAC8 as compared to vector-transfected cells (Fig.
6C). HDAC1 has previously been shown to be active when
immunoprecipitated from cell extracts [14,17], however,
HDAC8 shows no signi¢cant activity when immunoprecipi-
tated (Fig. 6B). This might be due to the loss of protein
factors during the enrichment, which are required for enzy-
matic activity of the HDAC8 protein, but might also re£ect
the fact that the acetylated H4 peptide is not a good substrate
for deacetylation by HDAC8. In fact, there is mounting evi-
dence that acetylation/deacetylation is not only utilized as a
means to alter chromatin states but is also involved in the
modi¢cation of a variety of proteins from transcription fac-
tors to proteins involved in nuclear transport [34,35]. Thus
HDAC8 may act on non-histone proteins, and may have
only limited deacetylation activity on histone proteins. The
failure to detect deacetylation of histones in the cells over-
expressing HDACs might be a consequence of the presence
of opposing HAT activities in the cells and thus, small
changes might not be detected due to the low sensitivity of
the Western blot assay.
In conclusion, we have cloned and characterized a novel
human HDAC cDNA which we designate HDAC8. HDAC
activity of HDAC8 is low compared to HDAC1 and the pre-
cise deacetylation target remains to be identi¢ed. The HDAC8
gene is located on the X chromosome at position q13 which
contains chromosomal breakpoints leading to some form of
leukemia and furthermore is involved in X chromosome in-
activation.
4. Note added in proof
Erding et al. [J. Biol. Chem. 275 (2000) 15254^15264] also
reported on the cloning and characterization of HDAC8.
Acknowledgements: We thank Yoichi Furukawa for kindly providing
a HDAC1 cDNA clone and Asifa Akhtar and Jimmy Van heusden
for critically reading the manuscript.
References
[1] Wol¡e, A.P. (1998) Chromatin: Structure and Function, 3rd
edn., Academic Press, London.
[2] Howe, L., Brown, C.E., Lechner, T. and Workman, J.L. (1999)
Crit. Rev. Eukaryot. Gene Expr. 9, 231^243.
[3] Grant, P.A. and Berger, S.L. (1999) Sem. Cell Dev. Biol. 10, 169^
177.
[4] Johnson, C.A. and Turner, B.M. (1999) Sem. Cell Dev. Biol. 10,
179^188.
[5] Khochbin, S. and Wol¡e, A.P. (1997) FEBS Lett. 419, 157^
160.
[6] Knoep£er, P.S. and Eisenman, R.N. (1999) Cell 99, 447^450.
[7] Ng, H.H. and Bird, A. (2000) Trends Biochem. Sci. 25, 121^126.
[8] Zhang, Y., Ng, H.H., Erdjument-Bromage, H., Tempst, P., Bird,
A. and Reinberg, D. (1999) Genes Dev. 13, 1924^1935.
[9] Wade, P.A., Gegonne, A., Jones, P.L., Ballestar, E., Aubry, F.
and Wol¡e, A.P. (1999) Nat. Genet. 23, 62^66.
[10] Huang, E.Y., Zhang, J., Miska, E.A., Guenther, M.G., Kouzar-
ides, T. and Lazar, M.A. (2000) Genes Dev. 14, 45^54.
[11] Glass, C.K. and Rosenfeld, M.G. (2000) Genes Dev. 14, 121^
141.
[12] Taunton, J., Hassig, C.A. and Schreiber, S.L. (1996) Science 272,
408^411.
[13] Yang, W.-M., Inouye, C., Zeng, Y., Bearss, D. and Seto, E.
(1996) Proc. Natl. Acad. Sci. USA 93, 12845^12850.
[14] Yang, W.-M., Yao, Y.-L., Sun, J.M., Davie, J.R. and Seto, E.
(1997) J. Biol. Chem. 272, 28001^28007.
[15] Emiliani, S., Fischle, W., Van Lint, C., Al-Abed, Y. and Verdin,
E. (1998) Proc. Natl. Acad. Sci. USA 95, 2795^2800.
[16] Dangond, F. and Gullans, S.R. (1998) Biochem. Biophys. Res.
Commun. 247, 833^837.
[17] Hassig, C.A., Tong, J.K., Fleischer, T.C., Owa, T., Grable, P.G.,
Ayer, D.E. and Schreiber, S.L. (1998) Proc. Natl. Acad. Sci.
USA 95, 3519^3524.
[18] Grozinger, C.M., Hassig, C.A. and Schreiber, S.L. (1999) Proc.
Natl. Acad. Sci. USA 96, 4868^4873.
[19] Miska, E.A., Karlsson, C., Langley, E., Nielsen, S.J., Pines, J.
and Kouzarides, T. (1999) EMBO J. 18, 5099^5107.
[20] Kao, H.Y., Downes, M., Ordentlich, P. and Evans, R.M. (2000)
Genes Dev. 14, 55^66.
[21] Kouzarides, T. (1999) Curr. Opin. Genet. Dev. 9, 40^48.
[22] Archer, S.Y. and Hodin, R.A. (1999) Curr. Opin. Genet. Dev. 9,
171^174.
[23] Gribskov, M., McLachlan, A.D. and Eisenberg, D. (1987) Proc.
Natl. Acad. Sci. USA 84, 4355^4358.
[24] Bairoch, A. and Apweiler, R. (1997) Nucleic Acids Res. 25, 31^
36.
[25] Heng, H.H.Q., Squire, J. and Tsui, L.-C. (1992) Proc. Natl.
Acad. Sci. USA 89, 9509^9513.
[26] Heng, H.H.Q. and Tsui, L.-C. (1993) Chromosoma 102, 325^332.
[27] Heng, H.H.Q. (1994) Methods Mol. Biol. 33, 35^49.
[28] Villard, L., Belougne, J., Lossi, A.-M., Fontes, M. and Colleaux,
L. (1999) Gene 235, 43^50.
[29] McDonnell, N., Ramser, J., Fransic, F., Vinet, M.C., Rider, S.,
Sudbrak, R., Riesselmann, L., Yaspo, M.L., Reinhardt, R.,
Monaco, A.P., Ross, F., Kahn, A., Kearney, L., Buckkle, V.
and Chelly, J. (2000) Genomics 64, 221^229.
[30] Rack, K.A., Chelly, J., Gibbons, R.J., Rider, S., Benjamin, D.,
Lafreniere, R.G., Oscier, D., Hendriks, R.W., Craig, I.W. and
Willard, H.F. et al. (1994) Hum. Mol. Genet. 3, 1053^1059.
[31] Dierlamm, J., Michaux, L., Criel, A., Wlodarska, I., Zeller, W.,
Louwagie, A., Michaux, J.L., Mecucci, C. and Van den Berghe,
H. (1995) Br. J. Haematol. 91, 885^891.
[32] Dewald, G.W., Brecher, M., Travis, L.B. and Stupca, P.J. (1989)
Cancer Genet. Cytogenet. 42, 173^185.
[33] Lyon, M.F. (1999) Curr. Biol. 9, R234^R237.
[34] Strahl, B.D. and Allis, C.D. (2000) Nature 403, 41^45.
[35] Kouzarides, T. (2000) EMBO J. 19, 1176^1179.
FEBS 23932 21-7-00 Cyaan Magenta Geel Zwart
I. Van den Wyngaert et al./FEBS Letters 478 (2000) 77^83 83
